134 related articles for article (PubMed ID: 24993691)
1. Stool methylated DNA markers decrease following colorectal cancer resection--implications for surveillance.
Kisiel JB; Yab TC; Taylor WR; Mahoney DW; Ahlquist DA
Dig Dis Sci; 2014 Aug; 59(8):1764-7. PubMed ID: 24993691
[TBL] [Abstract][Full Text] [Related]
2. Stool DNA methylation assays in colorectal cancer screening.
Kadiyska T; Nossikoff A
World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
[TBL] [Abstract][Full Text] [Related]
3. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue.
Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM
Dig Dis Sci; 2017 Mar; 62(3):678-688. PubMed ID: 28044229
[TBL] [Abstract][Full Text] [Related]
4. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates.
Kisiel JB; Yab TC; Taylor WR; Chari ST; Petersen GM; Mahoney DW; Ahlquist DA
Cancer; 2012 May; 118(10):2623-31. PubMed ID: 22083596
[TBL] [Abstract][Full Text] [Related]
5. Quantification of methylated markers with a multiplex methylation-specific technology.
Zou H; Allawi H; Cao X; Domanico M; Harrington J; Taylor WR; Yab T; Ahlquist DA; Lidgard G
Clin Chem; 2012 Feb; 58(2):375-83. PubMed ID: 22194633
[TBL] [Abstract][Full Text] [Related]
6. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.
Ahlquist DA; Zou H; Domanico M; Mahoney DW; Yab TC; Taylor WR; Butz ML; Thibodeau SN; Rabeneck L; Paszat LF; Kinzler KW; Vogelstein B; Bjerregaard NC; Laurberg S; Sørensen HT; Berger BM; Lidgard GP
Gastroenterology; 2012 Feb; 142(2):248-56; quiz e25-6. PubMed ID: 22062357
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
[TBL] [Abstract][Full Text] [Related]
8. Field Cancerization in Sporadic Colon Cancer.
Park SK; Song CS; Yang HJ; Jung YS; Choi KY; Koo DH; Kim KE; Jeong KU; Kim HO; Kim H; Chun HK; Park DI
Gut Liver; 2016 Sep; 10(5):773-80. PubMed ID: 27114416
[TBL] [Abstract][Full Text] [Related]
9. Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-Grade Dysplasia in Patients With Inflammatory Bowel Disease.
Kisiel JB; Klepp P; Allawi HT; Taylor WR; Giakoumopoulos M; Sander T; Yab TC; Moum BA; Lidgard GP; Brackmann S; Mahoney DW; Roseth A; Ahlquist DA
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):914-921.e5. PubMed ID: 29775793
[TBL] [Abstract][Full Text] [Related]
10. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
[TBL] [Abstract][Full Text] [Related]
11. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.
Kisiel JB; Yab TC; Nazer Hussain FT; Taylor WR; Garrity-Park MM; Sandborn WJ; Loftus EV; Wolff BG; Smyrk TC; Itzkowitz SH; Rubin DT; Zou H; Mahoney DW; Ahlquist DA
Aliment Pharmacol Ther; 2013 Mar; 37(5):546-54. PubMed ID: 23347191
[TBL] [Abstract][Full Text] [Related]
12. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
13. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
14. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance.
Johnson DH; Taylor WR; Aboelsoud MM; Foote PH; Yab TC; Cao X; Smyrk TC; Loftus EV; Mahoney DW; Ahlquist DA; Kisiel JB
Inflamm Bowel Dis; 2016 Jul; 22(7):1559-67. PubMed ID: 27104828
[TBL] [Abstract][Full Text] [Related]
16. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis.
Bagheri H; Mosallaei M; Bagherpour B; Khosravi S; Salehi AR; Salehi R
J Gene Med; 2020 Aug; 22(8):e3189. PubMed ID: 32196834
[TBL] [Abstract][Full Text] [Related]
17. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
[TBL] [Abstract][Full Text] [Related]
18. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers.
Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C
Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280
[TBL] [Abstract][Full Text] [Related]
19. Comparative detection of aberrantly methylated DNA in preoperative and postoperative stool from patients with colorectal cancers.
Nishioka Y; Ueki T; Hokazono K; Nagayoshi K; Tanaka M
Int J Biol Markers; 2015; 30(1):e81-7. PubMed ID: 24980446
[TBL] [Abstract][Full Text] [Related]
20. Multitarget stool DNA testing for colorectal-cancer screening.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]